A group of City executives and financiers has cooked up an audacious plan to revamp the Alternative Investment Market (AIM). The group, led by former London fintech boss Jon Prideaux, want to rebrand ...

A group of executives and financiers has in recent weeks met with companies and brokers to find backing for a plan to approach the London Stock Exchange with a proposal to revitalise its struggling ...

Avacta Therapeutics (AIM: AVCT), a life sciences company developing next generation peptide drug conjugates (PDC) targeting powerful anti-tumor payloads directly to the tumor, today announced that the ...